Fusheng Di

Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

Guoyu Jia, Fusheng Di, Wang Qipeng et al. · PLoS ONE · 2015 · 71 citations · Full text

Medicine, Internal Medicine, Pathology +17

A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

Huai Zhang, Christopher D. Byrne, Seung Up Kim et al. · Hepatology International · 2024 · 33 citations · Full text

Medicine, Biomedical Informatics, Clinical Classification Systems +12

[Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].

Guoyu Jia, Tao Han, Lei Gao et al. · PubMed · 2018 · 24 citations · Full text

Veterinary Medicine, Nutrition, Nutritional Sciences +14

The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China

Rui‐Xu Yang, Zhengsheng Zou, Bihui Zhong et al. · Hepatobiliary & pancreatic diseases international · 2021 · 20 citations

Medicine, Pathology, Hepatology +14

Regional difference in the susceptibility of non-alcoholic fatty liver disease in China

Mingfeng Xia, Xiaoyang Sun, Lili Zheng et al. · BMJ Open Diabetes Research & Care · 2020 · 14 citations · Full text

Medicine, Internal Medicine, Diabetology +16